Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene Augmentation in Schizophrenia Spectrum Disorder
NCT03043820Phase 3Completed
- Start
- Aug 2016
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raloxifene in schizophrenia spectrum and other psychotic disorders. Started Aug 2016; status: completed.
02
Drugs
raloxifene
03
Conditions
schizophrenia spectrum and other psychotic disorders
Beyond the preview
Go deeper on NCT03043820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03043820.